| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.38 | 1e-08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.003 |